Healthcare Triage: Orphan Drug Costs

Last week, we argued that the benefits of the Orphan Drug Act are more elusive than commonly assumed. But what are its costs? That’s the topic of this week’s Healthcare Triage.

Sources can be found in the posts Nick has written on the subject! Special thanks to him!

@aaronecarroll

Hidden information below

Aaron Carroll

Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist and tweets at @aaronecarroll. He is the Chief Health Officer at Indiana University. He is also a Distinguished Professor of Pediatrics and Associate Dean for Research Mentoring at the Indiana University School of Medicine. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.

The Incidental Economist

the health services research blog

Editors In Chief
Managing Editor

Work posted here under copyright © of the authors • Details on the Site Policies page

Subscribe

Email Address*